News

Sersense joins Mayo Clinic in a collaborative effort to develop a revolutionary inflammatory disease treatment funded by ARPA-H

Sersense, Inc. has been selected to participate in a groundbreaking research project led by Mayo Clinic. The initiative, funded by an ARPA-H with an award of up to $42.8 million, aims to create an implantable "living pharmacy" to treat inflammatory diseases such as Crohn's disease and ulcerative colitis.

Read more: https://newsnetwork.mayoclinic.org/discussion/mayo-clinic-secures-arpa-h-award-to-build-a-living-pharmacy-within-the-body-for-inflammatory-disease/

Oct 07, 2024